The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results

J Antimicrob Chemother. 1999 May:43 Suppl B:25-9. doi: 10.1093/jac/43.suppl_2.25.

Abstract

The in-vitro activities of moxifloxacin, ciprofloxacin, erythromycin and rifampicin against 49 Legionella spp. isolates were determined by an agar dilution method with buffered charcoal yeast extract agar containing alpha-ketoglutarate. Because the inhibitory effects of charcoal in the test media were pronounced (92% for quinolones, 90.5% for rifampicin and 92.5% for erythromycin), the MICs were corrected for the charcoal-bound fraction of the antibiotics. The corrected geometric mean MICs were 0.018 mg/L for moxifloxacin, 0.02 mg/L for ciprofloxacin, 0.27 mg/L for erythromycin and 0.005 mg/L for rifampicin.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / pharmacology*
  • Antibiotics, Antitubercular / pharmacology
  • Aza Compounds*
  • Ciprofloxacin / pharmacology
  • Culture Media
  • Drug Resistance, Microbial
  • Erythromycin / pharmacology
  • Fluoroquinolones*
  • Legionella / drug effects*
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Quinolines*
  • Rifampin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antibiotics, Antitubercular
  • Aza Compounds
  • Culture Media
  • Fluoroquinolones
  • Quinolines
  • Ciprofloxacin
  • Erythromycin
  • Moxifloxacin
  • Rifampin